Results

Total Results: 970 records

Showing results for "calculated".

881. Living Systematic Review on Cannabis for Chronic Pain – Quarterly Progress Report 2 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-q2-tables-f1-4.xlsx
     March 15, 2021 - hours Placebo spray (11.1 sprays/d) NA NA 15 Short NRS 83 167 49.7 77 172 44.77 NA NA NA NA NA NA EPC calculated … 24 hours Placebo spray (19.0 sprays/d) NA NA 5 Short NRS 16 63 25.4 9 62 14.52 NA NA NA NA NA NA EPC calculated … hours Placebo spray (14.2 sprays/d) NA NA 15 Short NRS 34 123 27.64 19 117 16.24 NA NA NA NA NA NA EPC calculated … max dose of 2 mg twice daily Placebo NA NA 5 Short NRS 11 13 84.62 5 13 38.46 NA NA NA NA NA NA EPC calculated

882. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
     August 01, 2012 - ASN suggests that AHRQ consider whether patients in the trials studied that is calculated from measurement … that direct GFR measurement is not performed in usual care, but rather it is estimated GFR that is calculated … Hence the prevalence estimates calculated by using the CKD-EPI are provided. … that is calculated from measurement of plasma creatinine.

883. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-update-2015_disposition-comments.pdf
     January 01, 2015 - Please explain in detail how an effect size was calculated in the absence of a metaanalysis and whether … We have changed this to represent the range in calculated OR of 1.2 to 1.6 for the studies. … We had used our calculated mean difference and measure of variability which was similar. … Public Reviewer Kathleen GansBrangs, Astrazeneca Figures Page 161 Figure 64Recommend verifying calculated … The odds ratio and 95% confidence interval are automatically calculated by the Stata program.

884. Who Uses Exenatide For Glucose Control in Diabetes Mellitus? A Retrospective Cohort Study of a New Therapy | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/diabetes-glucose-control/research
     August 04, 2010 - follows: the number of days that the patient had exenatide (or any type of insulin product) "on-hand" was calculated

885. Serum-Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research-protocol
     May 02, 2011 - According to the International Response Criteria, 10 the / ratio must be calculated to document a

886. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
     January 01, 2016 - Pooled risks were calculated using a random- effects model using the DerSimonian and Laird method.8

887. Suppl-2-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
     January 01, 2011 - This provision will be satisfied if the probability of selection is calculated conditional on A and

888. CER 205 Disposition of Comments for Physiologic Predictors of Severe Injury: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-205-predictors-trauma-care-disposition-comments.pdf
     April 01, 2018 - We calculated the sensitivity from the counts provided in the publication of the number of cases with

889. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
     October 05, 2010 - Methods Sorry if I missed this - was looking for info on how minimal clinical important difference was calculated

890. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-stenting-future_research.pdf
     January 01, 2014 - Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs Future Research Needs Paper Number 25 Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Stenting: Future Research Needs Future Research Nee…

891. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-strength-evidence.ppt
     June 01, 2012 - GRADE rate directness based on: Whether the test evaluated is used in practice If test accuracy is calculated … The GRADE directness rating takes into account whether test accuracy measures are calculated in a population

892. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-strength-evidence.ppt
     June 01, 2012 - GRADE rate directness based on: Whether the test evaluated is used in practice If test accuracy is calculated … The GRADE directness rating takes into account whether test accuracy measures are calculated in a population

893. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
     January 01, 2013 - Slide 1 Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research …

894. S9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s9.pdf
     October 01, 2007 - ORIGINAL ARTICLE Medicare Part D Data Major Changes on the Horizon Leslie M. Greenwald, PhD Background: The 3 primary administrative data sets developed by the Centers for Medicare and Medicaid services (CMS) to support the Medicare Part D program implementation represent a valuable source of data for health service…

895. Data Points 16: Types of Prostate Radiation: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-radiation_research.pdf
     November 01, 2012 - Data Points 16: Types of Prostate Radiation: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 Types of Prostate Radiation Data Points # 16 Changes across time and geography in the use of prostate radiation technologies for newly dia…

896. Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
     March 05, 2015 - Disposition of Comments for CER 147 Menopausal Symptoms: Comparative Effectiveness of Therapies Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Menopausal Symptoms: Comparative Effectiveness Review of Therapies Draft review available for public comment from Novemb…

897. Asthma-Immunotherapy-2010 Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
     January 01, 2010 - normality of continuous outcomes and calculate mean differences; standardized mean differences will be calculated

898. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - CDC also reported that researchers calculated that U.S. medical expenditures attributed to obesity totaled

899. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
     November 01, 2007 - In addition, for each of the different β-blockers, we calculated the proportion of days covered after … during the first 12 months following the index hospitalization by β-blocker exposure category were calculated … However, receipt of different types of β-blockers among β- blocker users may be non-random, so we calculated … Rates were calculated using Poisson regression with generalized estimating equations. 30.5 45.3 53.5

900. Data-Points-8 Tables1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
     January 01, 2009 - Antihypertensive Drugs, and Average Number of Antihypertensive Drug Classes Prescribed, 2006-2009 Note: Age is calculated … Hypertension and Use of One or More Antihypertensive Drugs, by Drug Class, 2006-2009 Note: Age is calculated … Antihypertensive Drugs Among Medicare Parts A, B, and D Beneficiaries With Hypertension, 2006-2009 Note: Age is calculated … Drug Class, Among Medicare Parts A, B, and D Beneficiaries With Hypertension, 2006-2009 Note:Age is calculated